Wed, August 8, 2018

Elemer Piros Maintained (APLS) at Buy with Increased Target to $53 on, Aug 8th, 2018

Elemer Piros of Cantor Fitzgerald, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $52 to $53 on, Aug 8th, 2018.

Elemer has made no other calls on APLS in the last 4 months.



There is 1 other peer that has a rating on APLS. Out of the 1 peers that are also analyzing APLS, 0 agree with Elemer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Elemer


  • Madhu Kumar of "B. Riley Securities" Upgraded from Hold to Strong Buy on, Monday, July 30th, 2018